TABLE 2.
HIV-1 integration site preference in PHA-activated, TN, and TCM CD4+ T cells
| Sample | No. (%) of unique integration sites |
Avg gene density within 1 Mb (±0.5 Mb) of integration sitesa | |||
|---|---|---|---|---|---|
| Total | Within RefSeq genes | Within 5 kb (±2.5 kb) of a transcriptional start site | Within 5 kb (±2.5 kb) of a CpG island | ||
| Activated CD4+ T cells | 133,697 | 114,110 (85.3)c | 6,242 (4.7)d | 7,052 (5.3)e | 20.3f |
| CD4+ TN cells | 729 | 613 (84.1)g | 30 (4.1%)h | 33 (4.5)i | 18.4j |
| CD4+ TCM cells | 2,620 | 2,291 (87.4)k | 109 (4.2%)l | 112 (4.3)m | 19.0n |
| MRCb | 50,000 | 22,328 (44.7) | 2,010 (4.0) | 2,100 (4.2) | 8.7 |
Based on complete genes.
Matched random control of 50,000 computer-generated integration sites in proximity to Mse1/BglII restriction sites in hg19.
P value (Fisher's exact test) versus values for the following: MRC, <2.2 × 10−308; TCM cells, 0.003; TN cells, 0.34.
P value (Fisher's exact test) versus values for the following: MRC, 1.7 × 10−9; TCM cells, 0.24; TN cells, 0.53.
P value (Fisher's exact test) versus values for the following: MRC, 1.0 × 10−21; TCM cells, 0.02; TN cells, 0.41.
P value (Wilcoxon rank-sum) versus values for the following: MRC, <2.2 × 10−308; TCM cells, 0.045; TN cells, 0.0002.
P value (Fisher's exact test) versus values for the following: MRC, 3.5 × 10−106; TCM cells, 0.02.
P value (Fisher's exact test) versus values for the following: MRC, 0.85; TCM cells, 1.
P value (Fisher's exact test) versus values for the following: MRC, 0.64; TCM cells, 0.76.
P value (Wilcoxon rank-sum) versus values for the following: MRC, 1.7 × 10−101; TCM cells, 0.017.
P value (Fisher's exact test) versus the value for the MRC, <2.2 × 10−308.
P value (Fisher's exact test) versus the value for the MRC, 0.72.
P value (Fisher's exact test) versus the value for the MRC, 0.84.
P value (Wilcoxon rank-sum) versus the value for the MRC, <2.2 × 10−308.